April 24 – 26 2017

Boston, USA


Full Event Guide

  • Brochure Thumbnail

    Full Event Guide

    Hear from 26 industry leaders as they reveal key insights on how gene therapies can become commercially successful in ophthalmic, CNS, hepatic, muscular and many other rare disorders.

    “I’m excited to come together with industry experts to discuss these challenges, as learning from each other’s experiences will enable us as a field to more rapidly advance this potentially transformative technology into the market to improve the lives of patients with rare diseases.” – Eileen Sawyer, Director, Global Medical Affairs, UniQure